Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
March 3, 2026
Asiatic acid promotes CD8+ T cell-mediated antitumor immunity by targeting HDAC8/CXCL10 axis in hepatocellular carcinoma
WM
Weifang Ma
Chinese Academy of Medical Sciences & Peking Union Medical College
XG
Xuelian Gao
Guangdong Provincial Center for Disease Control and Prevention
GZ
Ge Zeng
Nanfang Hospital
Ver todo
Puntos clave
Asiatic acid promotes enhanced CD8+ T cell-mediated antitumor immunity.
The investigation highlights a significant increase in CXCL10 levels after treatment with asiatic acid.
Assessment using a target approach revealed the involvement of the HDAC8 pathway.
The findings support further exploration of asiatic acid as a therapeutic option for hepatocellular carcinoma.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Liu et al. (Thu,) studied this question.
synapsesocial.com/papers/69a767ebbadf0bb9e87e2e34
https://doi.org/https://doi.org/10.1038/s41401-025-01739-9
Asiatic acid promotes CD8+ T cell-mediated antitumor immunity by targeting HDAC8/CXCL10 axis in hepatocellular carcinoma | Synapse